The Board of Directors of Zeria Pharmaceutical Co., Ltd. has authorized a buyback plan on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,042 JPY | +0.20% | +4.77% | +1.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.24% | 576M | |
+19.64% | 42.33B | |
+21.25% | 22.47B | |
+18.92% | 15.25B | |
+53.19% | 12.6B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.27% | 5.47B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Zeria Pharmaceutical Co., Ltd. authorizes a Buyback Plan.